Lyndra's Grant

Lyndra raised a round of funding on May 02, 2017. Investors include National Institute of Allergy and Infectious Diseases.

Lyndra aims to fundamentally change the way patients take medicines through the development of oral, ultra-long-acting, sustained release oral therapies that drastically improve healthcare outcomes. L…

Articles about Lyndra's Grant: